Douglas Harrington

DR. DOUGLAS HARRINGTON, Chairman of the Board and Chief Executive
Officer of , brings to the company over 18 years of experience in the
commercialization of healthcare technology. Prior to joining
ChromaVision in December 1996, Dr. Harrington served as Chairman and
President of Strategic Business Solutions, Inc., a privately held
company specializing in the commercialization of biotechnology, and as a
Principal in Douglas S. Harrington and Associates, a strategic
consulting firm. From 1992 to 1995, Dr. Harrington was President of
Nichols Institute, a publicly traded healthcare laboratory services
provider, now part of Quest Diagnostics, Inc. Prior to 1992, Dr.
Harrington held various management positions within Nichols Institute,
including Vice President of Operations and Medical Director. Dr.
Harrington currently sits on the Board of Directors, Advisory Board, or
Scientific Advisory Board of several other related healthcare and
medical device companies. In addition to his business experience, Dr.
Harrington is an Associate Professor of Clinical and Anatomic Pathology
at the University of Nebraska Medical Center and has authored over 80
peer-reviewed publications. He received a Bachelor’s of Arts degree with
distinction as well as a Medical degree from the University of Colorado
with specialties in Hematology and Anatomic and Clinical Pathology. He
has multiple professional affiliation memberships, including the
American Medical Association, the American Society of Clinical
Pathologists, the College of American Pathologists and the International
Academy of Pathology.